Our Pricing

Buy Mounjaro 5mg Single Pen - From £135.00 UK

Looking to buy Mounjaro 5mg single pen UK online with confidence? At Cured Pharmacy, you'll access genuine UK-licensed Mounjaro KwikPens from £135.00, supported by our GPhC-registered clinical team and superintendent pharmacist Tarun Kumar (GPhC 2233073). Every prescription begins with a free online consultation completed in under three minutes, ensuring safe, personalised weight management support.

How Mounjaro 5mg Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway medications, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation and metabolic function.

The 5mg dose serves as the initial maintenance level after a 2.5mg titration period, allowing your body to adapt gradually whilst minimising gastrointestinal side effects. In the SURMOUNT-1 trial, participants using tirzepatide achieved an average body weight reduction of 15% to 22.5% over 72 weeks, depending on final dose, compared to 2.4% with placebo [1]. This dual-receptor mechanism delivers superior clinical outcomes compared to single-pathway alternatives, making Mounjaro a leading choice for patients who haven't achieved their goals with diet and exercise alone.

Why Buy Mounjaro 5mg Single Pen from Cured Pharmacy

Cured Pharmacy offers transparent upfront pricing at £135.00 per Mounjaro 5mg pen, with no hidden consultation fees or membership charges. Our GPhC-registered pharmacy (9012511) dispenses only genuine UK-licensed medications sourced directly from authorised wholesalers, ensuring every pen meets MHRA quality standards.

Your prescription journey begins with a free clinical assessment by a UK-registered prescriber, completed online in under three minutes. Our clinical team reviews your medical history, current medications, and weight management goals to determine whether Mounjaro is suitable and safe for you. Once approved, your medication is dispensed by our superintendent pharmacist and delivered in 100% discreet packaging, typically arriving the next working day.

We guarantee the lowest Mounjaro prices in the UK. If you find a lower price from another UK-registered pharmacy for the same product, we'll match it. Our commitment to affordability ensures you can maintain consistent treatment without financial strain, supporting long-term weight management success.

What's Included with Your Mounjaro 5mg Order

Each Mounjaro 5mg single pen contains four pre-measured 0.5ml doses, designed for once-weekly subcutaneous injection. The KwikPen device features an intuitive dial mechanism and hidden needle system, making self-administration straightforward even for injection-naive patients. Your order includes the pen itself, plus access to our pharmacy support team for injection technique guidance and side effect management advice throughout your treatment.

Mounjaro 5mg Dosing Schedule and Titration

The recommended Mounjaro titration protocol begins with 2.5mg once weekly for four weeks, followed by an increase to 5mg weekly [2]. This gradual escalation minimises common gastrointestinal side effects such as nausea and diarrhoea, which typically resolve within the first month as your body adapts to the medication.

Most patients remain on the 5mg dose for at least four weeks before considering further increases. Your prescriber will assess your weight loss progress, tolerance, and side effect profile during follow-up consultations to determine whether dose escalation to 7.5mg, 10mg, 12.5mg, or the maximum 15mg is appropriate. Clinical trials demonstrate that higher doses produce greater weight reduction, but the 5mg level already delivers clinically significant results for many patients [1].

Consistency is crucial—administer your injection on the same day each week, at any time of day, with or without food. If you miss a dose and fewer than four days have passed, take it as soon as you remember. If more than four days have elapsed, skip the missed dose and resume your regular schedule. Never double up to compensate for a missed injection.

When to Consider Dose Adjustments

Your UK prescriber may recommend remaining on 5mg if you're achieving steady weight loss of 1-2 pounds weekly and tolerating the medication well. Alternatively, if weight loss plateaus after eight weeks or you experience minimal side effects, dose escalation may optimise results. Regular monitoring through our online consultation system ensures your treatment plan evolves with your progress, maximising both efficacy and safety.

Comparing Mounjaro 5mg to Other Weight Loss Treatments

Mounjaro's dual-receptor mechanism distinguishes it from semaglutide-based treatments like Wegovy and Saxenda, which activate only GLP-1 receptors. Head-to-head trials show tirzepatide produces approximately 25% greater weight reduction compared to semaglutide 2.4mg, the active ingredient in Wegovy [3]. This enhanced efficacy stems from GIP receptor activation, which amplifies insulin secretion and may improve fat metabolism beyond GLP-1 effects alone.

Oral medications like Orlistat work through an entirely different mechanism—blocking dietary fat absorption in the intestine rather than regulating appetite hormones. Orlistat typically produces 5-10% body weight reduction compared to Mounjaro's 15-22.5%, but may suit patients who prefer tablets over injections or have contraindications to GLP-1 therapies [4]. Mysimba, combining naltrexone and bupropion, targets central appetite pathways and delivers intermediate results between Orlistat and injectable GLP-1 treatments.

Your choice depends on multiple factors: previous treatment response, injection tolerance, budget, and medical history. Our UK prescribers assess these variables during your consultation to recommend the most appropriate option, whether that's Mounjaro or an alternative therapy better suited to your circumstances.

Managing Side Effects with Mounjaro 5mg

Gastrointestinal symptoms represent the most common side effects during Mounjaro treatment, affecting up to 30% of patients during dose escalation [2]. Nausea, diarrhoea, constipation, and reduced appetite typically emerge within the first week of a new dose and resolve within 2-4 weeks as your body adapts. These effects are generally mild to moderate and rarely require treatment discontinuation.

Practical strategies can minimise discomfort: eat smaller, more frequent meals rather than large portions; avoid high-fat and spicy foods that exacerbate nausea; stay well-hydrated, especially if experiencing diarrhoea; and consider taking anti-nausea medication like domperidone if symptoms persist beyond two weeks. Injection site reactions—redness, itching, or mild swelling—occur in fewer than 5% of patients and resolve spontaneously within 24-48 hours.

Serious side effects are rare but require immediate medical attention. Contact your GP or NHS 111 if you develop severe abdominal pain that doesn't resolve (possible pancreatitis), persistent vomiting preventing fluid intake (dehydration risk), or visual changes. Mounjaro carries a theoretical thyroid tumour risk based on rodent studies, though no human cases have been confirmed; nevertheless, it's contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [2].

When to Contact Your Prescriber

Reach out to our clinical team if side effects persist beyond four weeks, worsen rather than improve, or significantly impact your daily activities. We can adjust your titration schedule, provide symptom management strategies, or consider alternative treatments if Mounjaro proves unsuitable. Our pharmacy support line (116 4646009) is available during business hours for non-urgent questions about your treatment.

Who Can Buy Mounjaro 5mg Single Pen UK Online

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2]. You must have attempted weight loss through diet and exercise without achieving or maintaining clinically significant results. NICE guidance recommends considering pharmacotherapy when lifestyle interventions alone prove insufficient for patients meeting these criteria.

Certain medical conditions preclude Mounjaro use. You cannot be prescribed tirzepatide if you're pregnant, planning pregnancy, or breastfeeding; have personal or family history of medullary thyroid carcinoma or MEN 2; have severe gastrointestinal disease including inflammatory bowel disease; or have a history of pancreatitis. Patients with diabetic retinopathy require careful monitoring, as rapid glucose reduction may temporarily worsen eye complications.

During your free online consultation, our UK prescriber will review your complete medical history, current medications, and weight management goals. This assessment typically takes under three minutes but ensures Mounjaro is both safe and appropriate for your individual circumstances. If tirzepatide isn't suitable, your prescriber may recommend alternative treatments from our weight management range, including Wegovy, Saxenda, or oral medications, ensuring you still receive effective support.

Prescription Requirements and Clinical Assessment

All Mounjaro prescriptions require clinical approval by a UK-registered prescriber in accordance with General Medical Council and General Pharmaceutical Council guidelines. Our online consultation meets the same regulatory standards as face-to-face GP appointments, ensuring patient safety whilst offering the convenience of remote access. You'll receive a decision within 24 hours, and approved prescriptions are dispensed immediately by our GPhC-registered pharmacy team.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Electronic Medicines Compendium. (2023). Mounjaro 5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14298
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). https://www.nice.org.uk/guidance/cg189

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, diet, and exercise. Mounjaro is a prescription-only medicine and should only be used under medical supervision.